IntroductionTherapeutic non-adherence is a problem frequently encountered in patients suffering from psychotic disorders. It has consequences on the quality of life and on the prognosis of the evolution of the disease. It is essential to understand the causes in order to best support the patient towards adherence to care.ObjectivesThe objective of the study is to evaluate the therapeutic observance of patients hospitalized in the women’s department of the psychiatric hospital and to collect the reasons for therapeutic non-observance, as well as to identify the desired themes for the implementation group therapeutic education workshops.MethodsIt is a monocentric and prospective study, carried out in the women’s department through individual interviews on day 7 +/- 2 of the admission of patients to the psychiatric hospital of Tangier. The inclusion criteria are:-the patient’s consent,-the autonomous taking of a treatment before admission,-sufficient communication skillsThe psychometric tool used during this study is the MARS scale (Medication Adherence Report Scale) which allows the patient to assess his compliance, by answering 10 questions, assigning himself a score between 0 and 10 with a good compliance from 8/10. The discussion following the questionnaire makes it possible to identify the reason(s) for non-compliance and the themes to be addressed to improve compliance.ResultsOur first initial results were calculated from 60 patients admitted to hospital. Among them, 35 met the criteria for inclusion in the study. The interview takes place within an average of 8.0 ± 2.3 days. The average age is 40 ± 15 years. Patients present with schizophrenia in 80% of cases, bipolarity (8%) or borderline personality disorder (3%). Nine percent of patients have no diagnosis. Patients take an average of 2.5 drugs [1; 5] before hospitalization. The average MARS score is 5.6 ± 2.6. The reasons for non-adherence identified by patients are:-The presence of side effects,-Lack of means-Feeling of healing-The weariness of a long treatment-Inefficiency,-fear of interactions in case of toxic consumption-five patients declared observing and did not identify any reason for non-complianceConclusionsOur study has made it possible to better understand the difficulties and support needs of patients to improve their adherence to care. As a follow-up to this work, a multidisciplinary discussion will allow the setting up of group therapeutic education workshops around the identified themes.Disclosure of InterestNone Declared

Introduction: The World Health Organization (WHO) defined suicide as a deliberate act performed by a person who is fully aware of, or hopes for, its fatal outcome. According to the WHO, suicide accounts for 804,000 deaths worldwide and was considered a public health problem. However, suicide could be prevented by well-timed, evidence-based and often inexpensive interventions.In Morocco, the WHO estimated suicide rate of 7.3 per 100,000 inhabitants per year in 2019. However, there was a great lack of scientific and epidemiological data on this subject, hence the importance of early screening and psychometric evaluation. Objective: The purpose of our work was to provide the clinician with a non-exhaustive list of different scales used internationally to screen and assess suicidal risk. Method: This review of the literature used the following databases: PubMed science direct psychinfo. We used the following key words: scale, suicide risk screening. Discussion: Of the 9 tools listed above to assess suicidal risk, the two most frequently mentioned and used scales were the: Beck Scale for Suicide Ideation and The Columbia Suicide Severity Rating Scale (C-SSRS), despite the fact that they were not free of charge and had flaws in their structure (Andreotti ET 2020).the MINI suicide risk module (kadri, 2020) was the only validated scale in Arabic, in addition to being brief and free of charge. Other scales are available free of charge, notably the modified SAD PERSON Scale, the DUCHER scale, the suicide probability scale and the P4 screener. Conclusion: This review allowed us to list the screening scales for suicidal risk, in particular the SIDAS, P4, MINI SR module, DUCHER, BSS, CSSRs. The study helped creating a toolbox that might facilitate the task of clinicians in aim of early diagnosis and appropriate care.